Literature DB >> 33754220

Ankylosing spondylitis risk factors: a systematic literature review.

Mark C Hwang1, Lauren Ridley1, John D Reveille2.   

Abstract

Radiographic axial spondyloarthritis (also known as ankylosing spondylitis [AS]) is a chronic immune-mediated arthritis characterized by inflammation of the axial skeleton, peripheral joints, and entheses. It is estimated that 1 in every 200 people are affected by AS, making it an important healthcare and socioeconomic issue. In this review, we aim to explore the current understanding of AS risk factors and provide a comprehensive update. Multiple search strings were used to identify articles of interest published in PubMed between January 1, 2013, and February 1, 2021. On the basis of the literature review and analysis, we present up-to-date information on the risk factors of developing AS and our viewpoints on disease onset and progression. Multiple genetic and nongenetic risk factors have been suggested in the onset of AS. HLA-B27 is known to have a strong association with the disease, but other genes have been implicated in disease development. Aside from genetics, other factors are thought to be involved; up to 70% of patients with AS have subclinical intestinal inflammation, suggesting that the origin of the disease may be in the gut. The exact mechanism by which AS onset begins is most likely complex and multifactorial. Key Points • It remains unclear how interactions between genes, microbes, mechanical stress, gender, and other environmental and lifestyle factors predispose patients to the development of ankylosing spondylitis (AS). • The exact mechanisms of AS are complex and multifactorial which will require much future research • Recognizing the risk factors, as well as understanding gene-environment interactions, may offer valuable insights into the etiology of AS and have important implications for diagnosis and treatment strategies.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Ankylosing spondylitis; Genetics; HLA-B27; Pathogenesis; Radiographic axial spondyloarthritis; Risk factors

Mesh:

Substances:

Year:  2021        PMID: 33754220      PMCID: PMC9044547          DOI: 10.1007/s10067-021-05679-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  127 in total

1.  Association of polymorphisms in ERAP1 and risk of ankylosing spondylitis in a Chinese population.

Authors:  Yin Tang; Ping Yang; Fang Wang; Hui Xu; Shou-Yang Zong
Journal:  Gene       Date:  2017-12-24       Impact factor: 3.688

2.  Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitis.

Authors:  K Seager; H V Bashir; A F Geczy; J Edmonds; A de Vere-Tyndall
Journal:  Nature       Date:  1979-01-04       Impact factor: 49.962

3.  Association of ankylosing spondylitis with HLA-B*1403 in a West African population.

Authors:  Carlos López-Larrea; Moustafa Mijiyawa; Segundo González; J Luis Fernández-Morera; Miguel A Blanco-Gelaz; Jesús Martínez-Borra; Antonio López-Vázquez
Journal:  Arthritis Rheum       Date:  2002-11

4.  Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.

Authors:  Casper Webers; Ivette Essers; Sofia Ramiro; Carmen Stolwijk; Robert Landewé; Désirée van der Heijde; Filip van den Bosch; Maxime Dougados; Astrid van Tubergen
Journal:  Rheumatology (Oxford)       Date:  2015-09-18       Impact factor: 7.580

5.  Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation.

Authors:  Terry C C Lim Kam Sian; Saranjah Indumathy; Hanim Halim; Anja Greule; Max J Cryle; Paul Bowness; Jamie Rossjohn; Stephanie Gras; Anthony W Purcell; Ralf B Schittenhelm
Journal:  J Biol Chem       Date:  2019-11-18       Impact factor: 5.157

6.  Smoking quantity determines disease activity and function in Chinese patients with ankylosing spondylitis.

Authors:  Hui Zhang; Wei Wan; Jing Liu; Shengming Dai; Yaohong Zou; Qiaoxia Qian; Yue Ding; Xia Xu; Hengdong Ji; Hongjun He; Qi Zhu; Chengde Yang; Shuang Ye; Lindi Jiang; Jianping Tang; Qiang Tong; Dongyi He; Dongbao Zhao; Yuan Li; Yanyun Ma; Jingru Zhou; Zhendong Mei; Xiangxiang Chen; Ziyu Yuan; Juan Zhang; Xiaofeng Wang; Yajun Yang; Li Jin; Ying Gao; Xiaodong Zhou; John D Reveille; Hejian Zou; Jiucun Wang
Journal:  Clin Rheumatol       Date:  2018-03-27       Impact factor: 2.980

7.  HLA class I and II alleles in susceptibility to ankylosing spondylitis.

Authors:  John D Reveille; Xiaodong Zhou; MinJae Lee; Michael H Weisman; Lin Yi; Lianne S Gensler; Hejian Zou; Michael M Ward; Mariko L Ishimori; Thomas J Learch; Dongyi He; Mohammad H Rahbar; Jiucun Wang; Matthew A Brown
Journal:  Ann Rheum Dis       Date:  2018-10-19       Impact factor: 19.103

8.  Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression.

Authors:  Charlie Bridgewood; Dennis G McGonagle; Richard James Cuthbert; Abdulla Watad; Evangelos M Fragkakis; Robert Dunsmuir; Peter Loughenbury; Almas Khan; Peter A Millner; Adam Davison; Helena Marzo-Ortega; Darren Newton
Journal:  Ann Rheum Dis       Date:  2019-09-17       Impact factor: 19.103

9.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

10.  Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis.

Authors:  Sofia Ramiro; Robert Landewé; Astrid van Tubergen; Annelies Boonen; Carmen Stolwijk; Maxime Dougados; Filip van den Bosch; Désirée van der Heijde
Journal:  RMD Open       Date:  2015-09-14
View more
  9 in total

Review 1.  Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2021-10-21       Impact factor: 2.980

2.  Age-stratified trends in the progression of spinal radiographic damage in patients with ankylosing spondylitis: a longitudinal study.

Authors:  Tae-Han Lee; Bon San Koo; Bora Nam; Yun Jin Kim; Donghee Son; Seunghun Lee; Kyung Bin Joo; Tae-Hwan Kim
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-23       Impact factor: 3.625

3.  Distribution of Acute and Chronic Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis.

Authors:  Churong Lin; Dong Liu; Budian Liu; Jieruo Gu
Journal:  Int J Gen Med       Date:  2022-01-04

Review 4.  The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis.

Authors:  Hsien-Tzung Liao; Chang-Youh Tsai; Chien-Chih Lai; Song-Chou Hsieh; Yi-Syuan Sun; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Cheng-Hsun Lu; Yu-Min Kuo; Tzu-Hao Li; Chung-Tei Chou; Chia-Li Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20

5.  HLA-B27 may modulate the interaction between ERAP1 polymorphisms and smoking in ankylosing spondylitis patients.

Authors:  Javier Fernández-Torres; Yessica Zamudio-Cuevas; Nathalie Montaño-Armendariz; Iván Alejandro Luján-Juárez; Roberto Sánchez-Sánchez; Karina Martínez-Flores
Journal:  Mol Biol Rep       Date:  2022-04-16       Impact factor: 2.742

6.  T2 mapping and fat quantification of lumbar paraspinal muscle in ankylosing spondylitis: a case control study.

Authors:  Ruibin Huang; Hongwu Yang; Liujiang Chen; Shuyan Su; Xiaojia Wu; Ruyao Zhuang; Yuan Liu
Journal:  BMC Musculoskelet Disord       Date:  2022-06-27       Impact factor: 2.562

7.  Ankylosing Spondylitis and the Risk of Lung Cancer: A Meta-Analysis and Mendelian Randomization.

Authors:  Yiyuan Ao; Yaokai Wen; Yutian Li; Haoxin Peng; Xiangrong Wu; Zhufeng Wang; Yu Jiang; Yuechun Lin; Shuben Li
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

8.  Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.

Authors:  Liuting Zeng; Tiejun Yang; Kailin Yang; Ganpeng Yu; Jun Li; Wang Xiang; Hua Chen
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

9.  A2A adenosine receptor agonist reduced MMP8 expression in healthy M2-like macrophages but not in macrophages from ankylosing spondylitis patients.

Authors:  Omid Sadatpour; Mohammad Taha Ebrahimi; Maryam Akhtari; Nooshin Ahmadzadeh; Mahdi Vojdanian; Ahmadreza Jamshidi; Elham Farhadi; Mahdi Mahmoudi
Journal:  BMC Musculoskelet Disord       Date:  2022-10-12       Impact factor: 2.562

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.